 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- Alpha37 / Nordic Nanovector, Orano
Targeted alpha therapy with 212Pb-NNV003 in treatment of NHL (E-Poster Website) - Mar 9, 2022 - Abstract #AACR2022AACR_7003;
Treatment with 212Pb-NNV003 was superior to both ibrutinib and obinutuzumab. Further clinical testing is warranted.
- | Alpha37 / Nordic Nanovector, Orano
#NordicNanovector Announces EU Patent Granted Covering the Use of #Alpha37 $NANO https://t.co/mQFlOHyRJp (Twitter) - Jul 31, 2020